OpenVSafe by OpenVAERS
Search V-safe

6CT-79348-80944

3 vaccinations 7 coded responses 11 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
685 / NE
Registered
2022-07-23
Relationship
Child or adolescent in my care
Guardian
7PG-49656-80881
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-12
    Dose 1 — Moderna
  2. 2022-07-23
    Registered in v-safe
  3. 2022-07-23
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-26
    Survey response — day 14, dose 1, under 3
    MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Fair
    Free text: Cough (possibly due to teething), fever (presumably due to 6 month vaccines), runny nose
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-08-02
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  6. 2022-08-09
    Survey response — day 28, dose 1, under 3
    MedDRA: Teething — Feeling: Fair
    Free text: Teething
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-08-12
    Dose 2 — Moderna
  8. 2022-09-14
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-09-16
    Survey response — day 35, dose 2, under 3
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-09-23
    Survey response — day 42, dose 2, under 3
    MedDRA: Irritability, Nasopharyngitis, Rhinorrhoea, Teething — Feeling: Fair
    Free text: Runny nose, fussiness, rubbing eyes (has a cold and is teething)
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-11-11
    Survey response — 3 months, dose 2, under 3
    MedDRA: Ear infection, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: RSV, ear infection, various colds
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-11-11
    Report sent to call center — 3 months, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  13. 2022-11-14
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  14. 2022-12-30
    Dose 3 — Moderna
  15. 2023-02-10
    Survey response — 6 months, dose 2, under 3
    MedDRA: Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  16. 2023-03-31
    Survey response — 3 months, dose 3, under 3
    MedDRA: COVID-19, Febrile convulsion, Roseola — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    MedDRA releases: 2024-11
  17. 2023-03-31
    Report sent to call center — 3 months, dose 3, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  18. 2023-04-03
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  19. 2023-06-30
    Health check-in — 6 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-12Moderna No
22022-08-12Moderna No
32022-12-30Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-11-11 Successful
2022-11-14
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-03-31 Successful
2023-04-03
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-26

Symptoms: Cough (possibly due to teething), fever (presumably due to 6 month vaccines), runny nose

Release 12 (Under 3) — day 28, dose 1, under 3

2022-08-09

Symptoms: Teething

Release 12 (Under 3) — day 35, dose 2, under 3

2022-09-16

Symptoms: Cold symptoms

Release 12 (Under 3) — day 42, dose 2, under 3

2022-09-23

Symptoms: Runny nose, fussiness, rubbing eyes (has a cold and is teething)

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-11-11

Symptoms: RSV, ear infection, various colds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDEar infection · · ✓
SDFatigue · · ✓
SDFebrile convulsion · · ✓
SDIrritability · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDRoseola · · ✓
SDTeething · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release